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Purpose: Dry eye syndrome is one of the most common pathological manifestations in patients with chronic graft-versus-
host disease (cGVHD). When dry eye occurs in association with cGVHD, the local inflammation is secondary to the
systemic onset of inflammation. Toll-like receptor 2 (TLR2) signaling is thought to be essential for the inflammatory
response and for immune disorders. The aim of this study was to explore whether the TLR2-mediated nuclear factor-
kappa B (NF-κB) signaling pathway contributes to the inflammatory process of dry eye associated with cGVHD.
Methods: Twenty patients with dry eye related to cGVHD and 20 controls were enrolled in this study. The patients with
dry eye associated with cGVHD were diagnosed based on the clinical presentation and related ocular surface examinations
such as Schirmer’s test and fluorescein staining. In addition, dry eye symptom scoring (National Institutes of Health
consensus criteria) and Ocular Surface Disease Index (OSDI) scoring were also evaluated in all patients. Peripheral blood
was collected from the patients and the controls for subsequent experiments. mRNA levels of TLR2 and its downstream
molecules, NF-κB and tumor necrosis factor (TNF)-α, were measured by quantitative Real-Time PCR (qRT–PCR). The
protein level of TNF-α was detected by Enzyme-linked Immuno Sorbent Assay (ELISA).
Results: TLR2 mRNA in the peripheral blood from patients with dry eye related to cGVHD increased significantly
compared with the controls. NF-κB, the downstream target of TLR2, also showed a marked elevation. The mRNA and
protein levels of TNF-α were significantly upregulated in these patients. Importantly, the TLR2 level was strongly
correlated with the OSDI and the Schirmer’s test (r=0.565, p=0.010<0.05; r=0.564, p=0.016<0.05) in dry eye related to
cGVHD compared with the controls.
Conclusions: The TLR2-mediated NF–κB signaling pathway is activated in dry eye associated with cGVHD and
contributes to the inflammatory state, which may predict the onset and progression of dry eye associated with cGVHD.
Chronic graft-versus-host disease (cGVHD) is a serious
and  common  long-term  complication  of  allogeneic
hematopoietic stem cell transplantation (HSCT). Dry eye is
one  of  the  most  common  pathological  manifestations  of
cGVHD, occurring in up to 80% of patients [1]. Dry eye
associated with cGVHD can cause pain, ulcers or scars on the
cornea,  and  even  serious  visual  impairment,  adversely
affecting the performance of daily activities and impacting on
the quality of life [2-4]. Effective therapy is very limited in
this complex dry eye subgroup.
Studies have shown that dry eye associated with cGVHD
is  a  prolonged  inflammatory  state,  leading  to  progressive
organic destruction [5-7]. At an early stage of the pathological
process, donor T cells trigger antigen-presenting cells (APCs),
including monocytes, dendritic cells, and natural killer cells,
which have the potential to present antigens to naive T cells
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and activate effector T cells to produce a cytokine storm,
leading to these cells homing to and attacking target tissue.
Studies have indicated that a subclinical and complex cell-
mediated immune or inflammatory reaction takes place in the
conjunctiva of patients with dry eye secondary to cGVHD
[8] but that the local inflammation of the ocular surface is
secondary to the systemic onset of inflammation characterized
by  the  cytokine  storm  [1,5-7,9].  However,  the  crucial
signaling pathway that activates and mediates the systemic
inflammatory response in dry eye associated with cGVHD
remains to be fully elucidated.
Toll-like receptors (TLRs), which are a family of pattern
recognition  receptors,  can  provoke  innate  immunity  and
establish adaptive immunity, which can play a key role in
APCs initiating an effector T cell response [10,11]. Toll-like
receptor 2 (TLR2) on APCs can activate nuclear factor-kappa
B (NF-κB), an inducible transcription factor of inflammatory
signaling,  and  induce  the  production  of  inflammatory
cytokines and costimulatory molecules, both of which are
critical in autoimmunity and inflammation [12]. Many studies
have reported a potential immune role for TLR2 signaling in
the pathology of autoimmune-inflammatory diseases, such as
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2605systemic  lupus  erythematosus  [13],  arthritis  [14],  and
inflammatory bowel disease [15]. Obviously, the pathological
mechanism of dry eye associated with cGVHD involves an
autoimmune-inflammatory  abnormality.  Thus,  we
hypothesized  that  the  inflammatory  process  in  dry  eye
associated  with  cGVHD  might  be  mediated  in  part  by
activation of the immune pathway through TLR2.
In this study, we explored the expression of TLR2, as well
as cytokines related to the TLR2–NF-κB signaling pathway,
in dry eye associated with cGVHD. Our results showed that
TLR2 signaling was significantly activated in these patients,
suggesting that TLR2 contributes to the inflammatory state of
dry eye secondary to cGVHD.
METHODS
Patients: Twenty patients with prior HSCT who developed
cGVHD with dry eye manifestations were enrolled in this
study. Twenty patients who underwent HSCT but did not
suffer  from  dry  eye  associated  with  cGVHD  served  as
controls. The entire patients received bone marrow–sourced
perfectly human leukocyte antigen matched stem cells. Dry
eye associated with cGVHD was diagnosed when patients
with established cGVHD diagnoses presented with symptoms
and signs of dry eye disease according to the International Dry
Eye WorkShop report, 2007 [16]. Other etiologies of dry eye,
including Sjogren’s syndrome, Stevens-Johnson syndrome,
and contact lens–related dry eye, were clinically excluded.
Informed consent was obtained from all of the patients in
accordance with the Declaration of Helsinki, and the protocol
was  approved  by  the  Ethics  Committee  of  Guangdong
General Hospital.
Observation  and  assessment  of  dry  eye  associated  with
cGVHD:  It  is  difficult  to  evaluate  the  grades  of  dry  eye
associated with cGVHD due to the lack of uniform assessment
criteria. In this study, we used the National Institutes of Health
consensus criteria for organ scoring cGVHD to assess ocular
manifestations. Scores of 0 (none) to 3 (worst) were assigned.
Zero indicated no dry eye symptoms, 1 was defined as dry eye
symptoms not affecting activities of daily living (ADL; eye
drops ≤3 per day), 2 represented dry eye symptoms partially
affecting ADL (eye drops >3 per day or punctal plugs) without
vision  impairment,  and  3  indicated  dry  eye  symptoms
significantly affecting ADL (special eyewear to relieve pain)
or making it impossible to work [17]. Additionally, we used
the Ocular Surface Disease Index (OSDI) questionnaire to
quantitatively  evaluate  the  subjective  severity  of  dry  eye
disease.  The  OSDI  is  a  valid  and  reliable  instrument  for
measuring  the  severity  of  dry  eye  disease.  Scores  ranged
between 0 and 100, with higher scores representing more
severe dry eye symptoms [18]. The specialized Schirmer’s test
was performed to measure reflex tear secretion. Sterilized
strips of filter paper were placed in the lateral canthus away
from the cornea and left in place. Readings were reported in
millimeters of wetting for 5 min [19].
Quantitative real-time PCR analysis of TLR2, NF-κB, and
TNF-α  mRNA:  Quantitative  real-time  PCR  analysis  was
performed to detect the mRNA levels of TLR2, NF-κB, and
TNF-α  in  peripheral  blood  mononuclear  cells  (PBMCs).
Peripheral blood was collected by ethylenediamine tetraacetic
acid anticoagulation, and the PBMCs were separated using the
Ficoll-Hypaque gradient centrifugation method [20]. Total
RNA was extracted with a Trizol kit (Invitrogen, Carlsbad,
CA) and reversed into the first-strand cDNA by using random
hexamer primers and the reverse transcriptase Superscript II
Kit (Invitrogen) according to the manufacturer’s instructions.
PCR was performed in a total volume of 20 μl containing
2 μl of cDNA, 10 μl of 2× SYBR Premix Ex Taq, 0.8 μl of
50× ROX Reference Dye (TaKaRa Biotechnology Co., Ltd,
Dalian, PR, China), and 10 μmol/l primer pairs. The primers
are shown in Table 1. The following cycling conditions were
used: initial denaturation at 95 °C for 30 s, followed by 40
cycles at 95 °C for 5 s and 60 °C for 34 s according to the
manufacturer’s instructions. The 2(-ΔΔCT) method was used to
present the data of the gene of interest relative to an internal
control gene [21,22].
ELISA analysis of TNF-α: Venous blood samples (1–2 ml)
were  collected  from  the  patients  with  dry  eye  related  to
cGVHD and the controls. Levels of plasmatic TNF-α were
measured by ELISA (Bender MedSystem, Vienna, Austria)
according  to  the  standard  protocol  provided  by  the
manufacturer. The minimum detection level for the cytokine
was 23 pg/ml. When the calculated cytokine concentration
TABLE 1. SEQUENCES OF PRIMERS FOR REAL-TIME PCR USED IN THIS STUDY.
Primers Sequence Function
ACTB 5′-GCCAACACAGTGCTGTCTG-3′ Forward primer
  5′-TACTCCTGCTTGCTGATCCA-3′ Reverse primer
TLR2 5′-TGCTGCCATTCTCATTCTTCTG-3′ Forward primer
  5′-GCCACTCCAGGTAGGTCTTG-3′ Reverse primer
NF-кB 5′-TCTCGCCTGCCTCCACAAG-3′ Forward primer
  5′-TGTCTCCACGCCGCTGTC- 3′ Reverse primer
TNF-α 5′-ATCTACTCCCAGGTCCTCTTC-3′ Forward primer
  5′-GATGCGGCTGATGGTGTG-3′ Reverse primer
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undetectable.
Statistical analysis: Statistical analysis was performed using
the SPSS13.0 software package (SPSS Inc., Chicago, IL).
Data  are  shown  as  mean±standard  deviation  for  separate
experiments. The independent sample t-test analysis was used
for  the  mRNA  levels  of  TLR2,  NF-κB,  TNF-α  and  other
indicators in both study and control group. Spearman’s rank
correlation was computed to assess associations between the
variables.  A  p  value  <0.05  was  considered  statistically
significant.
RESULTS
Clinical and pathological evaluation of dry eye associated
with cGVHD: Baseline subject characteristics are depicted in
Table 2. There were no significant differences in age, sex, and
primary  disease  before  HSCT  between  both  groups.  As
expected,  levels  of  dry  eye  scores,  OSDI  scores,  and
Schirmer’s test scores were significantly increased in patients
with dry eye related to cGVHD compared with the controls.
As shown in Figure 1, fluorescein staining in a representative
patient  with  dry  eye  related  to  cGVHD  revealed  obvious
damage  to  the  corneal  epithelium  compared  with  control
patient.
Expression of TLR2 and its downstream molecules: Real-time
PCR results revealed that TLR2 expression showed a marked
increase in patients with dry eye related to cGVHD (2.48±2.35
versus  1.03±0.51,  p=0.019;  Figure  2).  The  PCR  analysis
(1.91±1.94 versus 0.88±0.18, p=0.001) showed that NF-κB,
TABLE 2. BASELINE SUBJECT CHARACTERISTICS.
Patient characteristics Dry eye with cGVHD Controls p-values
Male to female ratio 13:7 13:7  
Age 28.35±10.35 28.85±8.86 0.581
Primary disease before HSCT ALL:3/AML:10 CML:7 ALL:3/AML:4 CML:11/MDS:2  
Donor
Sibling 15 17  
Matched unrelated 5 3  
cGVHD grade
I - II 9 NA  
III- IV 11 NA  
Affected organ
Skin 16 NA  
Liver 8 NA  
Dry eye score 1.65±0.75 0 <0.001
OSDI score 31.85±8.11 73.25±18.78 0.047
Schermir test 3.72±1.54 7.55±2.68 0.001
        Abbreviations: ALL=acute Lymphoblastic Leukemia; AML=acute myeloid leukemia; CML=chronic myelogenous leukemia;
        MDS=myelodysplastic syndrome; OSDI=Ocular Surface Disease Index; NA=not applicable.
Figure 1. Corneal fluorescein staining
photographs. Slit-lamp microscopic and
fluorescein staining photographs from a
representative  patient  with  dry  eye
related to GVHD (A) and a control (B).
Green  punctate  positive  ﬂuorescein
staining in A highlights the erosion of
the  corneal  epithelium;  B  shows  an
intact corneal epithelium in a control.
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augmented in dry eye related to cGVHD (Figure 2).
Production of TNF-α cytokine: Stimulation of NF-κB can lead
to enhanced expression of inflammatory mediators such as
TNF-α. Therefore, we examined levels of TNF-α mRNA and
protein secretion in patients with dry eye related to cGVHD
and controls. As shown in Figure 3A,B, TNF-α mRNA levels
were elevated in the patients with dry eye related to cGVHD
(3.05±2.95 versus 0.99±0.40, p<0.001). The protein level of
TNF-α  detected  by  ELISA  showed  the  same  trend
(225.86±108.14  pg/ml  versus  134.44±29.294  pg/ml,
p=0.017).
Correlation  analysis:  There  were  significant  positive
correlations of TLR2 expression with the OSDI scores and
Schirmer’s  test  scores  (r=0.565,  p=0.010  <0.05;  r=0.564,
p=0.016 <0.05). In addition, NF-κB and TNF-α levels, the
inflammatory  pathway  molecules,  were  also  significantly
correlated  respectively  with  TLR2  expression  (r=0.509,
p=0.022 <0.05; r=0.565, p=0.009 <0.05).
DISCUSSION
An inflammatory and fibrotic process in patients with cGVHD
often produces debilitating dry eye syndrome [5-7]. cGVHD
may also affect the skin and be associated with liver damage.
There is increasing evidence that dry eye is accompanied by
ocular inflammation characterized by increased expression of
Figure 2. Expression of TLR2 and NF-κB in dry eye associated with
cGVHD. Enhanced expression of TLR2 and NF-κB was detected by
qRT–PCR in dry eye related to cGVHD compared with the controls.
Data from qRT–PCR are representative of three experiments and are
presented as mean±SEM (p≤0.05).
immune activation markers and infiltration of inflammatory
cells in cGVHD patients that exhibit an abnormal immune
reaction  and  systemic  inflammation  [5,8,9,23].  TLR2
signaling, mostly activated on APCs, has been considered
essential  for  the  inflammatory  response  and  for  immune
disorders. In this study, we measured and analyzed alterations
in the major components of TLR2 signaling in patients with
dry eye related to cGVHD. Of these patients, 16 had cutaneous
cGVHD with sclerodermoid features or erythema; eight had
liver  involvement  with  elevated  liver  function  tests  not
explained  by  medication  or  other  illnesses.  However,  we
found that TLR2 and its downstream targeted molecules were
remarkably upregulated in patients with dry eye related to
cGVHD.  Especially,  TLR2  expression  was  significantly
correlated with the dry eye profile such as OSDI scores and
Schirmer’s test in these patients.
Several studies have investigated the markedly impaired
immune function in the ocular surface of patients with dry eye
related to cGVHD [8,24]. In fact, dry eye related to cGVHD
is a systemic immune-inflammatory disorder. The local dry
eye  symptoms  are  secondary  to  the  systemic  disorders.
Therefore,  we  focused  on  the  systemic  inflammatory
response. To explore the molecular mechanisms underlying
the  induction  of  dry  eye  symptoms,  we  analyzed  the
expression of TLR2 and the related downstream cytokines in
peripheral blood. The findings relating to the activation of the
Figure 3. Increased TNF-α expression in patients with dry eye related
to cGVHD. TNF-α expression was elevated both in the mRNA (A)
and protein level (B) in dry eye related to cGVHD compared with
the controls. Data are presented as mean±SEM (p≤0.05).
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provide new insight into the inflammatory process of dry eye
associated with cGVHD. The up- or downregulation of these
TLR2–NF-κB signaling molecules might serve as potential
systemic indicators of the onset and progress of this disease
when compared with local inflammatory markers detected by
invasively scraping the conjunctival and corneal epithelium.
In recent years, TLRs have been reported to play a crucial
role  in  amplifying  autoimmune  responses,  ultimately
resulting  in  inflammation  [25].  Once  TLR  abnormalities
occur, they may cause excessive inﬂammation due to either
an  immoderate  innate  immune  response  or  to  persistent
compensatory  adaptive  immune  activation  [11].  TLR2
activation has been reported to have the potential to exacerbate
immune-inﬂammatory diseases in clinical and experimental
settings. For example, the expression of TLR2 and its ligands
is elevated in macrophages from the joints of patients with
rheumatoid  arthritis  [26].  Moreover,  some  novel  findings
suggest that TLRs may play major roles in the survival and
maintenance of grafted organs [27,28]. When TLR9 knockout
mice were used as graft recipients, survival and pathological
changes of acute intestinal GVHD were improved compared
with the wild-type recipient mice [29]. Some researchers have
reported that mutations in the TLR4 gene were associated with
an increased risk of severe acute GVHD [30,31]. However,
the  Goldstein  group  has  suggested  that  TLR2−/−  but  not
TLR4−/− recipient mice manifest a significant delay in graft
rejection  in  a  skin  allograft  model  [32,33].  Furthermore,
investigators have reported that TLR2 stimulation can induce
Th2 immunity [34,35], which is the prominent immunity of
chronic  GVHD,  whereas  TLR9  stimulation  promotes  Th1
immune  responses,  the  characterized  immunity  of  acute
GVHD [35]. Therefore, in this study we focused on TLR2 to
research the role of innate immunity in dry eye related to
chronic  GVHD.  Our  results  pointed  to  the  upregulated
expression of TLR2 and NF-κB, which efficiently trigger a
cytokine  storm  and  lead  to  the  inflammatory  response  in
patients with dry eye related to cGVHD.
NF-κB is a well known, classic inducible transcription
factor of many signaling pathway, and it has been found to
mediate the inflammatory role of TLR2 in several diseases
[36]. Many studies have reported that TLR2 can activate NF-
κB, termed the canonical pathway, to encode the inflammatory
gene-like TNF-α [37]. Some preliminary trials have tried to
regulate the inflammation of dry eye by neutralizing TNF-α
[38,39].  However,  the  upstream  molecules  of  this
inflammatory  signaling  pathway  have  not  been  clarified.
Exploring molecular mechanisms of TNF-α generation via the
TLR2–NF-κB signaling pathway should be quite useful for
developing  therapeutic  approaches  to  combat  dry  eye
associated with cGVHD. As we expected, our results showed
that there was a significant increase in the expression of NF-
κB and TNF-α and that this was positively correlated with
TLR2 upregulation. Thus, it is reasonable to conclude that
TLR2–NF-κB signaling is activated in dry eye associated with
cGVHD.
This preliminary study highlighted the potential role of
TLR2 signaling in dry eye associated with cGVHD. Various
mechanisms,  such  as  how  the  TLR2–NF-κB  signaling
pathway is activated, the molecular events underlying APCs-
T-cells  interactions  through  TLR2  activation,  and  the
inflammatory consequences of the activation of TLR2 on
APCs need further extensive investigation. We are currently
engaged in establishing a cGVHD model in TLR2 knockout
mice to elucidate the molecular mechanism underlying the
induction  of  cytokines/chemokines  by  TLR2  in  dry  eye
associated with cGVHD.
In  conclusion,  this  is  the  first  report  to  suggest  that
TLR2  and  NF-κB  expression  is  upregulated  in  dry  eye
associated with cGVHD and that this upregulation results in
the significant generation of proinflammatory factor TNF-α.
The  TLR2–NF-κB  signaling  pathway  contributes  to  the
inflammatory  state,  which  may  predict  the  onset  and
progression of dry eye associated with cGVHD. Our findings
provide  new  insights  into  the  molecular  mechanisms
underlying the control of the innate immune response in the
immunopathological  processes  of  dry  eye  associated  with
cGVHD. These, in turn, should contribute substantially to a
better  understanding  of  the  relationship  between  innate
immunity and dry eye associated with cGVHD.
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